Authors:
Company:
1Bakoulev National Medical Research Center of Cardiovascular Surgery of Ministry of Health of the Russian Federation,
Rublevskoe shosse, 135, Moscow, 121552, Russian Federation;
2 Vishnevskiy Institute of Surgery of Ministry of Health of the Russian Federation, str. Bolshaya Serpukhovskaya, 27,
Moscow, 115478, Russian Federation
E-mail: Сведения доступны для зарегистрированных пользователей.
Heading: Original Research
UDC: 616.132:616.12-005.4-006-089.819.5:612.115.3
Link: Clinical Physiology of Blood Circulaiton. 2018; 2 (1): 10-15
Quote as: Dombrovskiy M.M., Nikitina T.G., Samsonova N.N., Petrosyan K.V., Alekyan B.G., Bockeria L.A. Experience of antiplatelet therapy after percutaneous coronary intervention in patients with ischemic heart disease and oncopathology. Novosti Serdechno-Sosudistoy Khirurgii (Cardiovascular Surgery News). 2018; 2 (1): 10–5 (in Russ.).
Received / Accepted: 19.02.2018/26.02.2018
Chan A.O., Jim M.H., Lam K.F., Morris J.S., Siu D.C., Tong T. et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007; 298 (12): 1412–9.
Yang S.Y., Kim Y.S., Chung S.J., Song JH., Choi S.Y., Park M.J. et al. Association between colorectal adenoma and coronary atherosclerosis detected by CT coronary angiography in Korean men; a cross-sectional study. J. Gastroenterol. Hepatol. 2010; 25 (11): 1795–9.
Krone R.J. Managing coronary artery disease in the cancer patient. Prog. Cardiovasc. Dis. 2010; 53 (2): 149–56.
Chen C.L., Parameswaran R. Managing the risks of cardiac therapy in cancer patients. Semin. Oncol. 2013; 40 (2): 210–7.
Mistiaen W.P. Cancer in heart disease patients: what are the limitations in the treatment strategy? Future Cardiol. 2013; 9 (4): 535–47.
Hawn M.T., Graham L.A., Richman J.S., Itani K.M., Henderson W.G., Maddox T.M. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013; 310 (14): 1462–72.
Kałuza G.L., Joseph J., Lee J.R., Raizner M.E., Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J. Am. Coll. Cardiol. 2000; 35 (5): 1288–94.
Kristensen S.D., Knuuti J., Saraste A., Anker S., B/otker H.E., De Hert S. et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur. Heart J. 2014; 35 (35): 2383–431.
Fleisher L.A., Fleischmann K.E., Auerbach A.D., Barnason S.A., Beckman J.A., Bozkurt B. et al. 2014 АСС/АHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J. Am. Coll. Cardiol. 2014; 64 (22): e77–137.
Fujikawa T., Tanaka A. Successful multidisciplinary treatment of hilar cholangiocarcinoma in a patient with complicated newonset coronary artery disease. BMJ Case Rep. 2014; 2014.
Fukuyama K., Fujikawa T., Kuramitsu S., Tanaka A. Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation. BMJ Case Rep. 2014.
Savonitto S., D'Urbano M., Caracciolo M., Barlocco F., Mariani G., Nichelatti M. et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br. J. Anaesth. 2010; 104 (3): 285–91.
Rouine-Rapp K., McDermott M.W. Perioperative management of a neurosurgical patient with a meningioma and recent coronary artery stent. J. Clin. Anesth. 2013; 25 (3): 228–31.
Warshauer J., Patel V.G., Christopoulos G., Kotsia A.P., Banerjee S., Brilakis E.S. Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies. Catheter Cardiovasc. Interv. 2015; 85 (1): 25–31.
Ishikawa S., Kasai Y., Matsuura N., Tarumi S., Nakano J., Okuda M. et al. Perioperative management of lung cancer patients under antiplatelet or anticoagulant therapy. Kyobu Geka. 2015; 68 (4): 262–5.
Maki M., Tsubochi H., Endo T., Endo S. Management of patients with ischemic heart disease in lung cancer resection. Kyobu Geka. 2015; 68 (4): 271–7.
Kitamura Y., Suzuki K., Teramukai S., Sonobe M., Toyooka S., Nakagawa Y. et al. Feasibility of pulmonary resection for lung cancer in patients with coronary artery disease or atrial fibrillation. Ann. Thorac. Surg. 2017; 103 (2): 432–40.
Collet J.P., Roffi M., Byrne R.A., Costa F., Valgimigli M. Casebased implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease: The Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio- Thoracic Surgery (EACTS). Eur. Heart J. 2018; 39 (3): e1–e33.